# Clinical Documentation Standards

**Professional guidelines for healthcare software documentation**

---

## Overview

Clinical documentation in healthcare software requires precision, clarity, and adherence to regulatory requirements. This guide establishes standards for documenting healthcare systems, ensuring clinical accuracy, regulatory compliance, and usability for clinical end-users.

## Core Principles

### 1. Clinical Accuracy First
- **Use proper medical terminology**: Follow medical dictionaries and standard terminologies
- **Validate clinical content**: Review with clinical subject matter experts (SMEs)
- **Cite clinical evidence**: Reference clinical guidelines, medical literature
- **Maintain clinical context**: Explain the clinical "why" not just technical "how"

### 2. Regulatory Compliance
- **HIPAA considerations**: Document PHI handling, de-identification procedures
- **FDA requirements**: Follow FDA guidance for medical device labeling and IFU
- **ONC certification**: Document certified health IT capabilities
- **Audit requirements**: Enable compliance audits through clear documentation

### 3. Multi-Audience Approach
Documentation serves diverse audiences:
- **Clinicians**: Physicians, nurses, pharmacists, therapists
- **Clinical informaticists**: Implementation specialists, analysts
- **IT professionals**: System administrators, developers, integrators
- **Regulatory/compliance**: Privacy officers, quality assurance, auditors
- **Patients**: Patient-facing documentation (when applicable)

## Clinical Terminology Standards

### Use Standard Medical Vocabularies

**DO:**
- Use SNOMED CT preferred terms for clinical findings and disorders
- Use LOINC codes and short names for lab tests and observations
- Use RxNorm for medication names (generic names preferred)
- Use ICD-10-CM for diagnosis codes in documentation
- Use CPT for procedures when referencing billing/coding

**DON'T:**
- Create proprietary medical terminology
- Use abbreviations without expansion on first use
- Mix terminology systems inconsistently
- Use outdated or deprecated medical terms

### Approved Abbreviations

Use only JCAHO-approved abbreviations. **Never use** dangerous abbreviations:

**Prohibited Abbreviations:**
- U, u (unit) - Write "unit"
- IU (international unit) - Write "international unit"
- Q.D., QD (daily) - Write "daily"
- Q.O.D., QOD (every other day) - Write "every other day"
- Trailing zero (X.0 mg) - Write X mg
- Lack of leading zero (.X mg) - Write 0.X mg
- MS, MSO4 (morphine sulfate) - Write "morphine sulfate"
- MgSO4 (magnesium sulfate) - Write "magnesium sulfate"

**Acceptable Abbreviations:**
- BP (blood pressure)
- HR (heart rate)
- EHR (electronic health record)
- EMR (electronic medical record)
- CPOE (computerized provider order entry)
- CDS (clinical decision support)
- PHI (protected health information)
- ePHI (electronic protected health information)

### Clinical Writing Style

```markdown
# GOOD EXAMPLE - Clinical Documentation

## Medication Allergy Checking

The system performs real-time allergy checking when a provider enters a medication order via CPOE. The allergy checking algorithm:

1. **Retrieves active allergies**: Queries the patient's allergy list from the EHR
2. **Identifies allergen ingredients**: Extracts RxNorm ingredients from the ordered medication
3. **Performs cross-reactivity checking**: Compares ordered medication ingredients against known allergic substances, including cross-reactive drug classes (e.g., penicillin cross-reactivity with cephalosporins)
4. **Displays allergy alert**: If a match is found, displays a high-severity alert with:
   - Allergen name (SNOMED CT preferred term)
   - Reaction type (e.g., anaphylaxis, rash, nausea)
   - Reaction severity (mild, moderate, severe, life-threatening)
   - Date allergy was documented

**Clinical Safety Note**: Providers may override allergy alerts with documented justification. All overrides are logged for patient safety review.

**Evidence Base**: Allergy checking follows CPOE medication safety best practices documented in Bates et al., JAMA 1998, and CDS Five Rights framework (Right information, Right person, Right format, Right channel, Right time).
```

```markdown
# BAD EXAMPLE - Poor Clinical Documentation

## Allergy Check

The system checks allergies. If there's a match, it shows an alert. The doctor can override it.

[Problems: No clinical detail, no safety considerations, no evidence, too vague]
```

## Documentation Structure for Healthcare Systems

### System-Level Documentation

#### 1. Intended Use Statement
For all medical device software or clinical systems, document:

```markdown
## Intended Use

**Intended Use**: [Clear statement of medical purpose]

**Indications for Use**: [Specific clinical scenarios, patient populations]

**Intended Users**: [Clinical roles: physicians, nurses, etc.]

**Use Environment**: [Clinical settings: hospital, ambulatory, home]

**Contraindications**: [When system should NOT be used]

**Clinical Benefits**: [Expected clinical outcomes, evidence-based]

**Limitations**: [Clinical and technical limitations]
```

**Example:**
```markdown
## Intended Use

**Intended Use**: The CardioWatch™ Mobile ECG system is intended for the acquisition, display, storage, and transfer of ECG waveforms for patients 22 years and older.

**Indications for Use**: This device is indicated for use in the detection of cardiac arrhythmias in adult patients with known or suspected heart disease.

**Intended Users**: Licensed healthcare providers including cardiologists, primary care physicians, nurses, and cardiac technicians.

**Use Environment**: Outpatient clinics, physician offices, and monitored home use under physician supervision.

**Contraindications**: Not for use in patients under 22 years of age. Not for use as the sole method for diagnosing cardiac conditions. Not for use in life-sustaining or life-supporting applications.

**Clinical Benefits**: Enables early detection of atrial fibrillation, potentially reducing stroke risk through earlier anticoagulation therapy (evidence: AFFIRM trial, NEJM 2002).

**Limitations**: Cannot detect all arrhythmia types. ECG quality depends on proper sensor placement. Not suitable for continuous monitoring >24 hours.
```

#### 2. Clinical Workflow Documentation

Document integration with clinical workflows:

```markdown
## Clinical Workflow: Medication Ordering

### Pre-Conditions
- Provider has authenticated to EHR
- Patient chart is open
- Provider has prescribing privileges

### Clinical Workflow Steps

**Step 1: Order Initiation**
- **User Action**: Provider selects "New Medication Order"
- **System Response**: Displays medication search interface
- **Clinical Context**: System displays patient allergies, current medications, recent lab values (renal function, hepatic function)

**Step 2: Medication Selection**
- **User Action**: Provider searches for medication (generic or brand name)
- **System Response**: Returns medication list with:
  - Generic name (RxNorm)
  - Brand names
  - Available strengths and formulations
  - Formulary status (preferred, non-preferred, non-formulary)
- **Clinical Decision Support**:
  - Highlights formulary-preferred options
  - Shows patient's insurance coverage status
  - Displays patient's previous responses to medication (if previously prescribed)

**Step 3: Dose Selection**
- **User Action**: Selects strength, route, frequency, duration
- **System Response**:
  - Displays dose range checking
  - Shows age-based dosing guidance
  - Displays renal/hepatic dosing adjustments (if applicable)
- **Clinical Decision Support**:
  - **High-dose alert**: If dose exceeds maximum recommended
  - **Renal dosing alert**: If patient has CKD and dose adjustment needed
  - **Pediatric dosing alert**: For patients <18 years

**Step 4: Allergy and Interaction Checking**
- **System Action** (automated): Performs safety checks
  - Allergy checking (drug-allergy, class cross-reactivity)
  - Drug-drug interaction checking
  - Drug-disease contraindication checking
  - Duplicate therapy checking
- **System Response**: Displays alerts if safety issues detected
  - **Severity levels**: Critical (red), Significant (orange), Moderate (yellow), Minor (gray)
  - **Alert content**: Interaction description, clinical consequences, recommendations
- **User Action**: Reviews alerts, may modify order or override with justification

**Step 5: Order Signing**
- **User Action**: Electronically signs order
- **System Response**:
  - Order routed to pharmacy for verification
  - Medication added to patient's active medication list
  - Order appears in medication administration record (MAR)
  - Audit log entry created

### Post-Conditions
- Medication order is active
- Pharmacy has been notified
- Nursing can view order in MAR
- Patient's medication list is updated

### Error Handling
- **If provider lacks prescribing privileges**: Display error, refer to credentialing
- **If medication is controlled substance and provider lacks DEA authorization**: Block order, display notification
- **If allergy is critical and override attempted**: Require co-signature from supervising physician (configurable)

### Clinical Safety Considerations
- All orders require electronic signature (21 CFR Part 11 compliant)
- Critical allergy alerts require hard stop (cannot be overridden) - configurable by organization
- All alert overrides logged with justification for patient safety review
- Orders transmitted via HL7 ORM messages to pharmacy system with TLS encryption

### Regulatory Compliance
- Meets CPOE requirements for ONC 2015 Edition certification
- Supports e-Prescribing (NCPDP SCRIPT standard)
- Maintains audit trail per HIPAA audit controls requirement (45 CFR § 164.312(b))
```

#### 3. Data Model Documentation

Document clinical data structures:

```markdown
## Clinical Data Model: Patient Allergy

### FHIR Resource
Based on FHIR R4 AllergyIntolerance resource (US Core profile)

### Data Elements

| Element | Data Type | Cardinality | Clinical Definition | Terminology Binding |
|---------|-----------|-------------|---------------------|---------------------|
| patient | Reference(Patient) | 1..1 | Patient with the allergy/intolerance | N/A |
| clinicalStatus | CodeableConcept | 0..1 | active \| inactive \| resolved | AllergyIntoleranceClinicalStatusCodes |
| verificationStatus | CodeableConcept | 0..1 | confirmed \| unconfirmed \| refuted \| entered-in-error | AllergyIntoleranceVerificationStatusCodes |
| type | code | 0..1 | allergy \| intolerance | AllergyIntoleranceType |
| category | code | 0..* | food \| medication \| environment \| biologic | AllergyIntoleranceCategory |
| criticality | code | 0..1 | low \| high \| unable-to-assess | AllergyIntoleranceCriticality |
| code | CodeableConcept | 0..1 | Allergen or substance | SNOMED CT (disorder, substance), RxNorm (medication) |
| patient | Reference | 1..1 | Who the allergy is for | Patient resource |
| onset[x] | dateTime, Age, Period, Range, string | 0..1 | When allergy first manifested | N/A |
| recordedDate | dateTime | 0..1 | When allergy was recorded | N/A |
| recorder | Reference | 0..1 | Who recorded the allergy | Practitioner, Patient, RelatedPerson |
| reaction | BackboneElement | 0..* | Adverse reaction details | See below |
| reaction.substance | CodeableConcept | 0..1 | Specific substance causing reaction | SNOMED CT, RxNorm |
| reaction.manifestation | CodeableConcept | 1..* | Clinical symptoms (e.g., rash, anaphylaxis) | SNOMED CT (clinical finding) |
| reaction.severity | code | 0..1 | mild \| moderate \| severe | AllergyIntoleranceSeverity |
| reaction.exposureRoute | CodeableConcept | 0..1 | oral \| IV \| topical | SNOMED CT (route of administration) |

### Clinical Business Rules

1. **Criticality Assessment**:
   - If reaction.severity = "severe" OR reaction.manifestation includes anaphylaxis → set criticality = "high"
   - High criticality allergies trigger hard-stop alerts in CPOE

2. **Verification Status**:
   - Patient-reported allergies initially set to verificationStatus = "unconfirmed"
   - Provider-verified allergies set to verificationStatus = "confirmed"
   - Only "confirmed" allergies trigger clinical alerts (configurable)

3. **Clinical Status Management**:
   - Active allergies (clinicalStatus = "active") checked against medication orders
   - Resolved allergies (clinicalStatus = "resolved") displayed but don't trigger active alerts
   - Inactive allergies retained for historical reference

4. **Data Quality Rules**:
   - Allergy code must be present (SNOMED CT or RxNorm)
   - At least one reaction.manifestation required if reaction element present
   - recordedDate and recorder required for audit trail

### Example FHIR JSON

```json
{
  "resourceType": "AllergyIntolerance",
  "id": "example-penicillin-allergy",
  "clinicalStatus": {
    "coding": [{
      "system": "http://terminology.hl7.org/CodeSystem/allergyintolerance-clinical",
      "code": "active"
    }]
  },
  "verificationStatus": {
    "coding": [{
      "system": "http://terminology.hl7.org/CodeSystem/allergyintolerance-verification",
      "code": "confirmed"
    }]
  },
  "type": "allergy",
  "category": ["medication"],
  "criticality": "high",
  "code": {
    "coding": [{
      "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
      "code": "7980",
      "display": "Penicillin"
    }],
    "text": "Penicillin"
  },
  "patient": {
    "reference": "Patient/example"
  },
  "onsetDateTime": "2010-03-15",
  "recordedDate": "2023-06-10T14:30:00Z",
  "recorder": {
    "reference": "Practitioner/dr-smith"
  },
  "reaction": [{
    "manifestation": [{
      "coding": [{
        "system": "http://snomed.info/sct",
        "code": "39579001",
        "display": "Anaphylaxis"
      }],
      "text": "Anaphylaxis"
    }],
    "severity": "severe",
    "exposureRoute": {
      "coding": [{
        "system": "http://snomed.info/sct",
        "code": "26643006",
        "display": "Oral route"
      }]
    }
  }]
}
```

### HL7 v2.x Mapping

Maps to AL1 segment (Patient Allergy Information):

- AL1-2 (Allergen Type) ← category
- AL1-3 (Allergen Code) ← code
- AL1-4 (Allergy Severity) ← reaction.severity
- AL1-5 (Allergy Reaction) ← reaction.manifestation
- AL1-6 (Identification Date) ← recordedDate

### Database Schema

```sql
CREATE TABLE patient_allergies (
    allergy_id UUID PRIMARY KEY,
    patient_id UUID NOT NULL REFERENCES patients(patient_id),
    allergen_code VARCHAR(50) NOT NULL,
    allergen_code_system VARCHAR(100) NOT NULL, -- SNOMED CT, RxNorm
    allergen_display_name VARCHAR(255) NOT NULL,
    clinical_status VARCHAR(20) NOT NULL CHECK (clinical_status IN ('active', 'inactive', 'resolved')),
    verification_status VARCHAR(20) CHECK (verification_status IN ('confirmed', 'unconfirmed', 'refuted', 'entered-in-error')),
    allergy_type VARCHAR(20) CHECK (allergy_type IN ('allergy', 'intolerance')),
    category VARCHAR(20) CHECK (category IN ('food', 'medication', 'environment', 'biologic')),
    criticality VARCHAR(20) CHECK (criticality IN ('low', 'high', 'unable-to-assess')),
    onset_date DATE,
    recorded_date TIMESTAMP WITH TIME ZONE NOT NULL DEFAULT CURRENT_TIMESTAMP,
    recorder_id UUID REFERENCES users(user_id),
    created_at TIMESTAMP WITH TIME ZONE NOT NULL DEFAULT CURRENT_TIMESTAMP,
    updated_at TIMESTAMP WITH TIME ZONE NOT NULL DEFAULT CURRENT_TIMESTAMP,
    created_by UUID NOT NULL REFERENCES users(user_id),
    updated_by UUID NOT NULL REFERENCES users(user_id),

    -- Audit fields for HIPAA compliance
    row_version INTEGER NOT NULL DEFAULT 1,
    is_deleted BOOLEAN NOT NULL DEFAULT FALSE
);

CREATE TABLE allergy_reactions (
    reaction_id UUID PRIMARY KEY,
    allergy_id UUID NOT NULL REFERENCES patient_allergies(allergy_id),
    substance_code VARCHAR(50),
    substance_code_system VARCHAR(100),
    substance_display_name VARCHAR(255),
    manifestation_code VARCHAR(50) NOT NULL,
    manifestation_code_system VARCHAR(100) NOT NULL,
    manifestation_display_name VARCHAR(255) NOT NULL,
    severity VARCHAR(20) CHECK (severity IN ('mild', 'moderate', 'severe')),
    exposure_route_code VARCHAR(50),
    exposure_route_display_name VARCHAR(255),
    created_at TIMESTAMP WITH TIME ZONE NOT NULL DEFAULT CURRENT_TIMESTAMP
);

-- Index for allergy checking performance (critical for CPOE)
CREATE INDEX idx_patient_allergies_active ON patient_allergies(patient_id, clinical_status) WHERE clinical_status = 'active' AND is_deleted = FALSE;
CREATE INDEX idx_patient_allergies_allergen ON patient_allergies(allergen_code, allergen_code_system);
```

### Clinical Use Cases

1. **CPOE Allergy Checking**: Query active allergies when medication ordered, check for ingredient matches
2. **Allergy Reconciliation**: Compare home medication list against allergy list on admission
3. **Clinical Summary**: Display all allergies (active, resolved, inactive) in patient summary
4. **Quality Reporting**: Report percentage of patients with allergy list documented (Meaningful Use measure)
5. **Care Coordination**: Share allergy list via C-CDA document or FHIR API for care transitions
```

## User Interface Documentation

### Clinical UI Standards

```markdown
## Clinical Alert Display Guidelines

### Alert Severity Levels

| Severity | Visual Treatment | Use Case | User Action Required |
|----------|-----------------|----------|---------------------|
| **Critical** | Red background, bold text, blocking modal | Life-threatening (e.g., contraindicated medication with allergy history) | Hard stop - cannot proceed without attending physician co-signature |
| **High** | Orange/amber background, prominent display | Significant clinical risk (e.g., major drug-drug interaction) | Requires acknowledgment and override justification if proceeding |
| **Moderate** | Yellow background, inline alert | Clinical caution warranted (e.g., renal dose adjustment needed) | Acknowledgment required, override allowed |
| **Low** | Gray/blue background, informational | FYI information (e.g., formulary non-preferred medication) | Optional acknowledgment |

### Alert Content Requirements

Every clinical alert must include:

1. **Alert Title** (concise, clinical language): "Critical Drug Allergy: Penicillin"
2. **Clinical Problem** (what's wrong): "Patient has documented severe allergy to Penicillin (anaphylaxis)"
3. **Clinical Consequence** (why it matters): "Administering Amoxicillin may cause life-threatening anaphylactic reaction"
4. **Recommendation** (what to do): "Consider alternative antibiotic: Azithromycin or Fluoroquinolone"
5. **Evidence/Source** (why we're alerting): "Source: Patient allergy list (confirmed by Dr. Smith on 2023-06-10)"
6. **Action Options**:
   - Cancel order (recommended action prominently displayed)
   - Override with justification (requires text entry of clinical rationale)
   - Consult clinical pharmacist (if available)

### Alert Timing (CDS Five Rights)

- **Right Time**: Display at order entry, before order is signed
- **Right Person**: Show to ordering provider, not support staff
- **Right Format**: Modal dialog for critical, inline for informational
- **Right Channel**: Within CPOE workflow, not separate window
- **Right Information**: Specific to patient, specific to order

### Accessibility Requirements (Section 508)

- **Color is not the only indicator**: Use icons in addition to color (✗ for critical, ⚠ for warning, ℹ for info)
- **Screen reader compatible**: All alert content readable by screen readers
- **Keyboard navigation**: All actions accessible via keyboard (Tab, Enter, Esc)
- **Font size**: Minimum 12pt for alert text, 14pt for alert title
- **Contrast ratio**: Minimum 4.5:1 for text, 3:1 for UI components (WCAG 2.2 AA)
```

## API Documentation Standards

### Healthcare API Documentation

```markdown
## FHIR API Endpoint: Search Patients

### Endpoint
```
GET [base]/Patient?[parameters]
```

### Description
Searches for patients matching specified criteria. Implements FHIR R4 Patient resource search as defined in US Core Patient Profile v3.1.1.

### Authentication
- **Method**: OAuth 2.0 with OpenID Connect (SMART on FHIR)
- **Scopes Required**: `patient/Patient.read` or `user/Patient.read`
- **Token Type**: Bearer token in Authorization header

### Request Parameters

| Parameter | Type | Required | Description | Example |
|-----------|------|----------|-------------|---------|
| `_id` | token | Conditional | Logical ID of patient | `12345` |
| `identifier` | token | Conditional | Patient identifier (MRN, SSN) | `http://hospital.org/mrn|987654` |
| `name` | string | Conditional | Patient name (family or given) | `Smith` or `John` |
| `family` | string | No | Family name | `Smith` |
| `given` | string | No | Given name | `John` |
| `birthdate` | date | No | Date of birth (YYYY-MM-DD) | `1980-01-15` |
| `gender` | token | No | male | female | other | unknown | `male` |
| `_revinclude` | token | No | Include related resources | `Provenance:target` |

**Search Logic**: At least one of `_id`, `identifier`, or `name` must be provided.

### Request Example

```http
GET /fhir/r4/Patient?name=Smith&birthdate=1980-01-15&gender=male HTTP/1.1
Host: api.hospital.org
Authorization: Bearer eyJhbGciOiJSUzI1NiIsInR5cCI6IkpXVCJ9...
Accept: application/fhir+json
```

### Response

**Success Response (200 OK)**:

```json
{
  "resourceType": "Bundle",
  "type": "searchset",
  "total": 1,
  "link": [
    {
      "relation": "self",
      "url": "https://api.hospital.org/fhir/r4/Patient?name=Smith&birthdate=1980-01-15&gender=male"
    }
  ],
  "entry": [
    {
      "fullUrl": "https://api.hospital.org/fhir/r4/Patient/example",
      "resource": {
        "resourceType": "Patient",
        "id": "example",
        "meta": {
          "versionId": "1",
          "lastUpdated": "2023-06-10T14:30:00Z",
          "profile": ["http://hl7.org/fhir/us/core/StructureDefinition/us-core-patient"]
        },
        "identifier": [
          {
            "use": "usual",
            "type": {
              "coding": [{
                "system": "http://terminology.hl7.org/CodeSystem/v2-0203",
                "code": "MR",
                "display": "Medical Record Number"
              }]
            },
            "system": "http://hospital.org/mrn",
            "value": "987654"
          }
        ],
        "active": true,
        "name": [
          {
            "use": "official",
            "family": "Smith",
            "given": ["John", "Michael"]
          }
        ],
        "gender": "male",
        "birthDate": "1980-01-15",
        "address": [
          {
            "use": "home",
            "line": ["123 Main St", "Apt 4B"],
            "city": "Boston",
            "state": "MA",
            "postalCode": "02101",
            "country": "US"
          }
        ]
      }
    }
  ]
}
```

**Error Responses**:

| Status Code | Scenario | Response Body |
|-------------|----------|---------------|
| 400 Bad Request | Missing required search parameters | OperationOutcome: "Must provide at least one of: _id, identifier, or name" |
| 401 Unauthorized | Invalid or missing access token | OperationOutcome: "Invalid access token" |
| 403 Forbidden | Insufficient scopes | OperationOutcome: "Access denied. Required scope: patient/Patient.read" |
| 404 Not Found | No patients match criteria | Bundle with total=0, empty entry array |
| 429 Too Many Requests | Rate limit exceeded | OperationOutcome: "Rate limit exceeded. Retry after 60 seconds" |
| 500 Internal Server Error | Server error | OperationOutcome: "Internal server error. Contact support@hospital.org" |

### Clinical Safety Considerations

- **Patient Matching**: Use fuzzy matching algorithm to account for name variations (nicknames, misspellings)
- **Duplicate Detection**: Multiple matching patients may indicate duplicate records - display warning to user
- **PHI Protection**: Search results filtered based on user's authorized patient panel (patient/Patient.read) or role-based access (user/Patient.read)
- **Audit Logging**: All patient searches logged per HIPAA audit controls requirement

### Performance Characteristics

- **Response Time**: p50: 150ms, p95: 500ms, p99: 1000ms
- **Rate Limits**: 100 requests per minute per client application
- **Pagination**: Results paginated at 50 patients per page (use `_count` parameter to adjust, max 100)
- **Cache**: Patient demographics cached for 5 minutes

### Compliance Notes

- **HIPAA**: All API access logged with user ID, timestamp, patient accessed
- **ONC Certification**: Meets (g)(10) Standardized API for patient and population services
- **US Core**: Fully implements US Core Patient Profile v3.1.1 (USCDI v1)
```

## Regulatory Documentation Standards

### FDA Submission Documentation

For medical device software requiring FDA submission:

```markdown
## Software Description (FDA 510(k) Section 5)

### Device Name
CardioWatch™ Mobile ECG System

### Software Version
Version 2.1.0 (Build 2.1.0.453)

### Software Safety Classification
**IEC 62304 Class B** - Software that could contribute to a hazardous situation resulting in minor injury

**Justification**: Software processes ECG signals and displays to clinician for interpretation. Software failure could result in missed arrhythmia detection, but clinical correlation and additional diagnostic methods are standard of care. Not life-supporting or life-sustaining.

### Software Development Standards
- IEC 62304:2006 Medical device software - Software life cycle processes
- ISO 14971:2019 Application of risk management to medical devices
- IEC 62366-1:2015 Usability engineering for medical devices

### Software Development Environment
| Component | Tool | Version |
|-----------|------|---------|
| Programming Language | Swift | 5.8 |
| IDE | Xcode | 14.3 |
| Version Control | Git | 2.40 |
| Build System | Xcode Build System | 14.3 |
| Testing Framework | XCTest | - |
| Static Analysis | SwiftLint | 0.52.2 |

### Software Requirements Specification (SRS)
Total Requirements: 247
- Functional Requirements: 189
- Performance Requirements: 28
- Interface Requirements: 18
- Safety Requirements: 12

**Traceability**: All requirements traced to design specifications, code modules, and test cases (see Traceability Matrix TM-001).

### Risk Management Summary
**Risk Management Plan**: RMP-CardioWatch-001
**Risk Management Report**: RMR-CardioWatch-2.1.0

**Hazards Identified**: 23
**Hazard Mitigations Implemented**: 23
**Residual Risks**: All within acceptable limits (ALARP - As Low As Reasonably Practicable)

**Key Hazards and Mitigations**:

1. **Hazard**: False negative arrhythmia detection due to signal processing error
   - **Risk Before Mitigation**: Medium (Severity: Moderate, Probability: Occasional)
   - **Mitigation**: Implemented validated signal quality assessment algorithm; Low-quality signals flagged and not analyzed
   - **Residual Risk**: Low (Severity: Minor, Probability: Remote)

2. **Hazard**: Incorrect patient identified due to user error
   - **Risk Before Mitigation**: High (Severity: Serious, Probability: Probable)
   - **Mitigation**: Implemented barcode scanning for patient wristband; Added patient photo display for visual confirmation; Required two-factor patient identification
   - **Residual Risk**: Low (Severity: Minor, Probability: Remote)

### Software Verification and Validation (V&V)
**V&V Plan**: VVP-CardioWatch-001
**V&V Report**: VVR-CardioWatch-2.1.0

**Test Cases Executed**: 1,247
- Unit Tests: 892
- Integration Tests: 247
- System Tests: 89
- Usability Tests: 19

**Test Pass Rate**: 100% (all defects resolved)
**Traceability**: All requirements validated through testing (see Traceability Matrix TM-001)

### Cybersecurity
Cybersecurity addressed per FDA Guidance "Content of Premarket Submissions for Management of Cybersecurity in Medical Devices" (October 2014).

**Security Features**:
- User authentication (username/password, minimum 8 characters, complexity requirements)
- Data encryption at rest (AES-256)
- Data encryption in transit (TLS 1.2)
- Automatic session timeout (15 minutes of inactivity)
- Audit logging of all PHI access
- Secure software update mechanism (code signing, cryptographic verification)

**Threat Modeling**: Conducted STRIDE threat modeling (see Cybersecurity Risk Assessment CSRA-001)
**Penetration Testing**: Third-party penetration testing conducted (see report PT-CardioWatch-2023)

### Software Labeling
**Instructions for Use (IFU)**: Document IFU-CardioWatch-2.1.0
**User Manual**: Document UM-CardioWatch-2.1.0
**Quick Start Guide**: Document QSG-CardioWatch-2.1.0

**Labeling includes**:
- Intended use and indications for use
- Contraindications and warnings
- User instructions with screenshots
- Troubleshooting guide
- Technical specifications
- Cybersecurity information
- Contact information for technical support

### Software Maintenance Plan
**Post-Market Surveillance**: Ongoing monitoring for software defects, cybersecurity vulnerabilities
**Software Updates**: Security patches released within 30 days of vulnerability disclosure
**Adverse Event Reporting**: Medical device reporting (MDR) per 21 CFR Part 803

**Version Control Strategy**:
- Major releases (X.0.0): New features, significant changes - require FDA submission
- Minor releases (1.X.0): Minor features, non-safety changes - may require FDA notification
- Patch releases (1.0.X): Bug fixes, security patches - documented in Device Master Record

### Design History File (DHF) Contents
1. Software Requirements Specification (SRS-CardioWatch-2.1.0)
2. Software Design Specification (SDS-CardioWatch-2.1.0)
3. Risk Management Plan and Report (RMP-001, RMR-2.1.0)
4. V&V Plan and Report (VVP-001, VVR-2.1.0)
5. Traceability Matrix (TM-001)
6. Usability Engineering File (UEF-CardioWatch-2.1.0)
7. Cybersecurity Risk Assessment (CSRA-001)
8. Software Bill of Materials (SBOM-CardioWatch-2.1.0)
9. Known Anomalies List (KAL-CardioWatch-2.1.0)
10. Version Description Document (VDD-CardioWatch-2.1.0)
```

## Change Control Documentation

### Clinical System Change Management

```markdown
## Change Request: CR-2023-456

### Change Summary
Implement clinical alert for QTc prolongation when prescribing QT-prolonging medications

### Change Classification
**Type**: Enhancement
**Category**: Clinical Decision Support
**Regulatory Impact**: Yes - affects clinical safety, requires validation
**HIPAA Impact**: No - does not change PHI handling

### Clinical Justification
**Problem**: Clinicians may inadvertently prescribe QT-prolonging medications to patients at risk for QTc prolongation, increasing risk of Torsades de Pointes (potentially fatal arrhythmia).

**Evidence**:
- CredibleMeds QTdrugs list (www.crediblemeds.org)
- ACC/AHA guidelines on QT prolongation
- FDA drug safety communications on QT prolongation

**Expected Benefit**: Reduce adverse drug events related to QT prolongation by 30% (based on literature from Tisdale et al., JACC 2013)

### Affected Systems
- CPOE medication ordering module
- Clinical decision support (CDS) rules engine
- Patient medication list
- ECG results interface

### Requirements

**Functional Requirements**:
1. System shall retrieve most recent ECG with QTc measurement for patient
2. System shall calculate patient's QTc prolongation risk score (Tisdale Risk Score)
3. System shall check if ordered medication is on CredibleMeds QTdrugs list
4. System shall display alert if:
   - Patient's most recent QTc > 500 msec, OR
   - Patient's Tisdale Risk Score ≥ 11 (high risk), OR
   - Patient is on multiple QT-prolonging medications (> 2 concurrent)
5. Alert shall display:
   - Patient's QTc value and date measured
   - Tisdale Risk Score with risk factors
   - Other QT-prolonging medications on active medication list
   - Clinical recommendation: Consider alternative medication OR order ECG monitoring

**Non-Functional Requirements**:
1. Alert response time < 2 seconds
2. Alert accuracy (sensitivity) ≥ 95%
3. Alert positive predictive value ≥ 30% (to minimize alert fatigue)

### Risk Assessment

**Clinical Risks**:
1. **False negative** (missed QTc prolongation risk): Mitigated by using evidence-based risk score and credible drug list
2. **False positive** (unnecessary alert): Mitigated by using threshold QTc > 500 msec and high-risk score
3. **Alert fatigue**: Mitigated by limiting alerts to high-risk scenarios

**Technical Risks**:
1. **ECG interface failure**: Mitigated by alert still firing if no ECG available but risk score high
2. **Performance degradation**: Mitigated by caching CredibleMeds list, indexing ECG results

### Validation Plan

**Validation Protocol**: VP-QTc-Alert-001

**Test Scenarios** (20 total):
1. Patient with QTc > 500 msec, order QT-prolonging medication → Alert displayed ✓
2. Patient with QTc < 500 msec, Tisdale score < 11, order QT-prolonging med → No alert ✓
3. Patient on 3 QT-prolonging meds, order 4th → Alert displayed ✓
4. ... (17 additional scenarios)

**Usability Testing**:
- 10 clinicians (5 physicians, 5 NPs) complete test scenarios
- Measure: Alert comprehension, action taken, time to decision
- Success criteria: ≥ 90% correct interpretation, ≥ 80% appropriate action

**Clinical Validation**:
- Review by cardiology clinical SME
- Review by clinical pharmacist
- Approval by Clinical Decision Support Committee

### Deployment Plan

**Phase 1 - Pilot** (2 weeks):
- Deploy to cardiology clinic only
- Monitor alert firing rate, override rate
- Collect clinician feedback

**Phase 2 - Staged Rollout** (4 weeks):
- Week 1: Internal medicine
- Week 2: Family medicine
- Week 3: Emergency department
- Week 4: All other departments

**Phase 3 - Monitoring** (Ongoing):
- Weekly review of alert analytics
- Monthly review of override rates and justifications
- Quarterly review of clinical outcomes (QT-related adverse events)

### Rollback Plan
If alert firing rate > 50 alerts/day (indicating excessive false positives):
1. Immediately disable alert
2. Review firing criteria with clinical SMEs
3. Adjust thresholds and re-validate
4. Re-deploy with updated criteria

### Approval Signatures
- **Clinical Owner**: Dr. Sarah Johnson, Cardiologist (signed 2023-11-15)
- **Quality Assurance**: Mark Williams, QA Manager (signed 2023-11-16)
- **IT Director**: Jennifer Lee, IT Director (signed 2023-11-16)
- **Compliance Officer**: Robert Chen, Privacy & Compliance (signed 2023-11-16)
```

---

## Summary

Healthcare software documentation requires:

1. **Clinical accuracy** using standard medical terminologies
2. **Regulatory compliance** with HIPAA, FDA, ONC requirements
3. **Multi-audience approach** serving clinicians, IT, compliance, patients
4. **Evidence-based content** citing clinical guidelines and research
5. **Safety-first mindset** documenting clinical risks and mitigations
6. **Comprehensive traceability** from requirements through validation
7. **Clear workflows** showing clinical integration and context
8. **Accessible design** meeting Section 508 and WCAG standards

All documentation must be maintained under change control, reviewed by clinical SMEs, and validated for clinical accuracy and regulatory compliance.

---

**Version**: 1.0
**Last Updated**: 2025-11-19
**References**:
- FDA Guidance for Industry - Cybersecurity for Medical Devices
- FDA Guidance - Content of Premarket Submissions for Device Software Functions
- ONC 2015 Edition Health IT Certification Criteria
- IEC 62304:2006 Medical Device Software Lifecycle
- HL7 FHIR R4 Specification
- Google Developer Documentation Style Guide (adapted for healthcare)
